Bone morphogenetic protein signaling inhibitor improves differentiation and function of 3D muscle construct fabricated using C2C12
- 10 April 2024
- journal article
- research article
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 137 (6) , 480-486
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (21K04787)
This publication has 36 references indexed in Scilit:
- Recent advances in animal cell technologies for industrial and medical applicationsJournal of Bioscience and Bioengineering, 2022
- In Vitro Model of Human Skeletal Muscle Tissues with Contractility Fabricated by Immortalized Human Myogenic CellsAdvanced Biosystems, 2020
- Fabrication of contractile skeletal muscle tissues using directly converted myoblasts from human fibroblastsJournal of Bioscience and Bioengineering, 2020
- Engineered skeletal muscle tissue for soft robotics: fabrication strategies, current applications, and future challengesWIREs Nanomedicine and Nanobiotechnology, 2013
- Factors affecting the structure and maturation of human tissue engineered skeletal muscleBiomaterials, 2013
- Role of endogenous TGF‐β family in myogenic differentiation of C2C12 cellsJournal of Cellular Biochemistry, 2010
- Dorsomorphin and LDN-193189 inhibit BMP-mediated Smad, p38 and Akt signalling in C2C12 cellsThe International Journal of Biochemistry & Cell Biology, 2010
- Preparation of artificial skeletal muscle tissues by a magnetic force-based tissue engineering techniqueJournal of Bioscience and Bioengineering, 2009
- Smad1 and Smad5 Act Downstream of Intracellular Signalings of BMP-2 That Inhibits Myogenic Differentiation and Induces Osteoblast Differentiation in C2C12 MyoblastsBiochemical and Biophysical Research Communications, 1997
- Bone Morphogenetic Protein-2 Inhibits Terminal Differentiation of Myogenic Cells by Suppressing the Transcriptional Activity of MyoD and MyogeninExperimental Cell Research, 1997